Skip to content

Analyses of the skin molecules in the patient of atopic dermatitis.

Analyses of the skin molecules in the patient of atopic dermatitis. - Analyses of the skin molecules in the patient of atopic dermatitis.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000027285
Enrollment
30
Registered
2017-05-23
Start date
2017-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

None listed

Sponsors

Kao Corporation
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1.Japanese male panelists who are 20-59 years old. 2.Panelists with atopic dermatitis more than mild condition. 3.Panelists who have normal weight (BMI: Between 18.5 and 25.0) 4.Panelists who agree to have their typical daily routines.

Exclusion criteria

Exclusion criteria: 1.Panelists who use the steroid and immunosuppressant in face for more than 2 weeks during a month. 2.Panelists who used the antibiotics in the last 2 weeks. 3.Panelists who have the disease, such as diabetes, affecting on this study. 4.Panelists who use the drugs affecting on this study. 5.Panelists who have undergone some beauty treatments on their faces. 6.Panelists participating in, or scheduled to participate in, another study during the study period. 7.Panelists who smoke.

Design outcomes

Primary

MeasureTime frame
The relationship between skin molecules and status of atopic dermatitis.

Secondary

MeasureTime frame
The relationship between skin molecules and questionnaires.

Countries

Japan

Contacts

Public ContactTakayoshi Inoue

Kao Corporation R&D -Core Technology- Biological Science Research

inoue.takayoshi@kao.co.jp0285-68-7498

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026